A carregar...

Erlotinib Effectively Inhibits JAK2(V617F) Activity and Polycythemia Vera Cell Growth

JAK2(V617F), a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The JAK2 mutant displays a much increased kinase activity and generates a PV-like phenotype in mou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Zhe, Xu, Mingjiang, Xing, Shu, Ho, Wanting Tina, Ishii, Takefumi, Li, Qingshan, Fu, Xueqi, Zhao, Zhizhuang Joe
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2096634/
https://ncbi.nlm.nih.gov/pubmed/17178722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.C600277200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!